FindTrial
Sign In

Evaluation of Knowledge, Attitude and Practice (KAP) of Pharmacists towards novel coronavirus pneumonia (COVID-19): A Cross-Sectional Study

Evaluation of Knowledge, Attitude and Practice (KAP) of Pharmacists towards novel coronavirus pneumonia (COVID-19): A Cross-Sectional Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035213
Enrollment
Unknown
Registered
2020-08-03
Start date
2020-08-10
Completion date
Unknown
Last updated
2020-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Case series:Online questionnaire

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Pharmacy workforce including hospital pharmacists, community pharmacists, pharmaceutical laboratory practitioners and etc.

Exclusion criteria

Exclusion criteria: 1. Pharmacists who refuse to take the survey; 2. Questionnaires with contradictory answers.

Design outcomes

Primary

MeasureTime frame
Pharmacists' knowledge of COVID-19;Pharmacists' attitude to COVID-19;Practice provided by pharmacists;—

Contacts

Public ContactRongsheng ZHAO

Peking University Third Hospital

zhaorongsheng@bjmu.edu.cn+86 10 82265810

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026